Hepatitis C in Clinically Discordant Hemophilic Siblings
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
This observational or N/A phase trial investigates Blood Disease and Hemophilia A and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 6 recorded versions since 1999 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Sep 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of North Carolina, Chapel Hill
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.